GlassScriptPhysician profile
James I Youssef
NPI 1417273152
$7,789.89
in general payments reported to CMS, 2019-2025
25 companies · $4,614 in 2025
The $4,614 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $319 · 2021: $187 · 2022: $605 · 2023: $740 · 2024: $1,032 · 2025: $4,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,861 · Travel and Lodging: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,861.36 |
| Travel and Lodging | $524.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $3,619.23 | 2019-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $992.33 | 2020-2025 | Wainua, Farxiga |
| Abbott Laboratories | $616.01 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Intuitive Surgical, INC. | $594.84 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.76 | 2019-2023 | Lifevest |
| Nuvasive, INC. | $290.28 | 2022 | |
| Bridgebio Pharma, INC. | $192.97 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $140.70 | 2020 | |
| Amgen INC. | $139.67 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $134.96 | 2022-2025 | Verquvo |
| Pfizer INC. | $128.39 | 2022-2025 | |
| Abiomed | $112.14 | 2025 | |
| Boston Scientific Corporation | $87.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.13 | 2022-2023 | Camzyos |
| Becton, Dickinson and Company | $42.30 | 2025 | Progel Applicator Spray Tips |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $42.20 | 2022-2025 | |
| Heartflow, INC. | $42.03 | 2025 | |
| Preventice Services, LLC | $28.93 | 2021 | |
| Impulse Dynamics (USA) INC. | $26.44 | 2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $24.53 | 2020 | |
| Lilly USA, LLC | $22.00 | 2023 | Mounjaro |
| Scpharmaceuticals INC. | $20.90 | 2025 | |
| Janssen Pharmaceuticals, INC | $19.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.42 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.